Nguyen, Quan Dong
Sepah, Yasir J.
Berger, Brian
Brown, David
Do, Diana V.
Garcia-Hernandez, Alberto
Patel, Sunil
Rahhal, Firas M.
Shildkrot, Yevgeniy
Renfurm, Ronny W.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema
https://doi.org/10.1186/s40942-019-0178-7
Funding for this research was provided by:
Astellas Pharma, Inc., Northbrook, IL
Article History
Received: 1 April 2019
Accepted: 4 June 2019
First Online: 1 August 2019